China · Delayed Price · Currency is CNY Boji Medical Technology Statistics
Total Valuation
SHE:300404 has a market cap or net worth of CNY 4.64 billion. The enterprise value is 4.33 billion.
| Market Cap | 4.64B |
| Enterprise Value | 4.33B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
SHE:300404 has 383.08 million shares outstanding. The number of shares has increased by 0.52% in one year.
| Current Share Class | 383.08M |
| Shares Outstanding | 383.08M |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | +2.79% |
| Owned by Insiders (%) | 35.05% |
| Owned by Institutions (%) | 1.82% |
| Float | 243.60M |
Valuation Ratios
The trailing PE ratio is 80.60.
| PE Ratio | 80.60 |
| Forward PE | n/a |
| PS Ratio | 4.56 |
| PB Ratio | 4.18 |
| P/TBV Ratio | 4.47 |
| P/FCF Ratio | 95.60 |
| P/OCF Ratio | 66.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 78.35, with an EV/FCF ratio of 89.34.
| EV / Earnings | 74.85 |
| EV / Sales | 4.26 |
| EV / EBITDA | 78.35 |
| EV / EBIT | 161.64 |
| EV / FCF | 89.34 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.84 |
| Quick Ratio | 1.33 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.73 |
| Debt / FCF | 0.83 |
| Interest Coverage | 19.64 |
Financial Efficiency
Return on equity (ROE) is 5.30% and return on invested capital (ROIC) is 3.29%.
| Return on Equity (ROE) | 5.30% |
| Return on Assets (ROA) | 1.01% |
| Return on Invested Capital (ROIC) | 3.29% |
| Return on Capital Employed (ROCE) | 2.33% |
| Weighted Average Cost of Capital (WACC) | 6.59% |
| Revenue Per Employee | 848,181 |
| Profits Per Employee | 48,310 |
| Employee Count | 1,198 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 3.13 |
Taxes
In the past 12 months, SHE:300404 has paid 3.66 million in taxes.
| Income Tax | 3.66M |
| Effective Tax Rate | 5.99% |
Stock Price Statistics
The stock price has increased by +20.52% in the last 52 weeks. The beta is 0.43, so SHE:300404's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +20.52% |
| 50-Day Moving Average | 12.92 |
| 200-Day Moving Average | 10.93 |
| Relative Strength Index (RSI) | 49.36 |
| Average Volume (20 Days) | 32,037,444 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300404 had revenue of CNY 1.02 billion and earned 57.88 million in profits. Earnings per share was 0.15.
| Revenue | 1.02B |
| Gross Profit | 244.21M |
| Operating Income | 26.80M |
| Pretax Income | 61.05M |
| Net Income | 57.88M |
| EBITDA | 53.30M |
| EBIT | 26.80M |
| Earnings Per Share (EPS) | 0.15 |
Balance Sheet
The company has 367.29 million in cash and 40.09 million in debt, with a net cash position of 327.20 million or 0.85 per share.
| Cash & Cash Equivalents | 367.29M |
| Total Debt | 40.09M |
| Net Cash | 327.20M |
| Net Cash Per Share | 0.85 |
| Equity (Book Value) | 1.11B |
| Book Value Per Share | 2.77 |
| Working Capital | 478.21M |
Cash Flow
In the last 12 months, operating cash flow was 69.65 million and capital expenditures -21.17 million, giving a free cash flow of 48.49 million.
| Operating Cash Flow | 69.65M |
| Capital Expenditures | -21.17M |
| Depreciation & Amortization | 26.50M |
| Net Borrowing | -3.27M |
| Free Cash Flow | 48.49M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 24.03%, with operating and profit margins of 2.64% and 5.70%.
| Gross Margin | 24.03% |
| Operating Margin | 2.64% |
| Pretax Margin | 6.01% |
| Profit Margin | 5.70% |
| EBITDA Margin | 5.25% |
| EBIT Margin | 2.64% |
| FCF Margin | 4.77% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.11%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.11% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 13.25% |
| FCF Payout Ratio | 10.27% |
| Buyback Yield | -0.52% |
| Shareholder Yield | -0.41% |
| Earnings Yield | 1.24% |
| FCF Yield | 1.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 2, 2022. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2022 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |